AAAAAA

   
Results: 1-3 |
Results: 3
alpha-amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1
Authors: Becker, DP Barta, TE Bedell, L DeCrescenzo, G Freskos, J Getman, DP Hockerman, SL Li, M Mehta, P Mischke, B Munie, GE Swearingen, C Villamil, CL
Citation: Dp. Becker et al., alpha-amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1, BIOORG MED, 11(20), 2001, pp. 2719-2722
Effect of interferon beta-1b in MS - Assessment of annual accumulation of PD/T2 activity on MRI
Authors: Zhao, GJ Koopmans, RA Li, DKB Bedell, L Paty, DW
Citation: Gj. Zhao et al., Effect of interferon beta-1b in MS - Assessment of annual accumulation of PD/T2 activity on MRI, NEUROLOGY, 54(1), 2000, pp. 200-206
Treatment adherence and patient retention in the first year of a Phase-IIIclinical trial for the treatment of multiple sclerosis
Authors: Mohr, DC Goodkin, DE Masuoka, L Dick, LP Russo, D Eckhardt, J Boudewyn, AC Bedell, L
Citation: Dc. Mohr et al., Treatment adherence and patient retention in the first year of a Phase-IIIclinical trial for the treatment of multiple sclerosis, MULT SCLER, 5(3), 1999, pp. 192-197
Risultati: 1-3 |